-
May 04, 2011
Hologic lacks exciting growth, but the technology is in place for better growth in the future.
-
May 04, 2011
Teva's acquisition of Cephalon is a logical deal that solves problems for each company.
-
April 28, 2011
Becton Dickinson is a great company with improving prospects that is ideal for long-term investors.
-
April 28, 2011
Healthcare is an increasingly worthwhile destination for dividend shoppers.
-
April 26, 2011
Despite flooding of its key Australian operations, Peabody Energy scored tremendous profits in its first quarter.
-
April 25, 2011
Abbott has made some curious moves of late, but the value is still there.
-
April 25, 2011
St. Jude faces something it has rarely seen in the past - high expectations.
-
April 21, 2011
Although an investor should always hold a diversified portfolio to minimize company-specific risks, a selection of ...
-
April 18, 2011
These five Brazilian stocks boast market-beating yields and highlight the growth potential of this growing economy.
-
April 15, 2011
Here are five stocks with dividend yields over 4% with a solid company behind them.
-
April 12, 2011
With energy prices continuing to rise, this BRIC nation could be a good bet for the remainder of the year.
-
April 12, 2011
Check out five low-beta stocks that can help you to diversify your portfolio.
-
April 12, 2011
Endo makes an unusual move to get into the device space.
-
April 08, 2011
Growth and dividends don't have to be an either/or choice.
-
April 01, 2011
The market loves a good story stock, but sometimes, the math behind the story doesn't paint a very pretty picture.
-
March 30, 2011
VimpelCom is moving aggressively to build a global network of emerging markets.
-
March 28, 2011
Despite what you may hear or read about coal, its use in the U.S. isn't going away anytime soon.
-
March 28, 2011
A low P/E ratio is a great starting point for inquisitive investors.
-
March 24, 2011
John Malone is taking cable global and Germany is one of his big plays.
-
March 22, 2011
Quest shows once again that it is willing to pay for what may become valuable testing technology.
